|
|
||||||||
American Journal of Roentgenology, Vol 172, 1527-1533, Copyright © 1999 by American Roentgen Ray Society
ARTICLES |
K Ito, DG Mitchell, EK Outwater and R Blasbalg
Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
OBJECTIVE: The purpose of this study was to evaluate the spectrum of MR imaging features of primary sclerosing cholangitis. MATERIALS AND METHODS: A retrospective review was performed of MR imaging findings including MR cholangiography and multiphasic contrast-enhanced dynamic sequences in 22 patients with primary sclerosing cholangitis. MR imaging analysis included abnormalities of intra- and extrahepatic bile ducts, abnormalities of liver parenchyma, changes in liver morphology, and lymphadenopathy. RESULTS: Abnormal findings of bile ducts were seen in all 22 patients; the most common finding was intrahepatic bile duct dilatation (77%), followed by intrahepatic bile duct stenosis (64%), extrahepatic bile duct wall enhancement (67%), extrahepatic bile duct wall thickening (50%), extrahepatic bile duct stenosis (50%), and intrahepatic bile duct beading (36%). Increased enhancement of the liver parenchyma on dynamic arterial-phase images, predominantly in the peripheral areas of the liver, was identified in 56% of patients. Other findings included periportal lymphadenopathy (77%), periportal high signal intensity on T2-weighted images (68%), hypertrophy of the caudate lobe (68%), and abnormal hyperintensity of the liver parenchyma on T1-weighted images (23%). CONCLUSION: On MR imaging, primary sclerosing cholangitis showed several characteristic features, including bile duct abnormalities and increased enhancement of the liver parenchyma. MR cholangiography and contrast-enhanced dynamic MR techniques are useful for revealing intra- and extrahepatic signs of primary sclerosing cholangitis.
This article has been cited by other articles:
![]() |
M. Bilgin, N. C. Balci, A. Erdogan, A. J. Momtahen, S. Alkaade, and W. S. Rau Hepatobiliary and Pancreatic MRI and MRCP Findings in Patients with HIV Infection Am. J. Roentgenol., July 1, 2008; 191(1): 228 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Knowlton, A. J. Taylor, M. Reichelderfer, and J. Stang Imaging of Biliary Tract Inflammation: An Update Am. J. Roentgenol., April 1, 2008; 190(4): 984 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Gandhi, M. A. Brown, J. G. Wong, D. A. Aguirre, and C. B. Sirlin MR Contrast Agents for Liver Imaging: What, When, How RadioGraphics, November 1, 2006; 26(6): 1621 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Bader, K. L. Beavers, and R. C. Semelka MR Imaging Features of Primary Sclerosing Cholangitis: Patterns of Cirrhosis in Relationship to Clinical Severity of Disease Radiology, March 1, 2003; 226(3): 675 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Keogan and R. R. Edelman Technologic Advances in Abdominal MR Imaging Radiology, August 1, 2001; 220(2): 310 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Fulcher, M. A. Turner, K. J. Franklin, M. L. Shiffman, R. K. Sterling, V. A. C. Luketic, and A. J. Sanyal Primary Sclerosing Cholangitis: Evaluation with MR Cholangiography-A Case-Control Study Radiology, April 1, 2000; 215(1): 71 - 80. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |